Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00252954Phase 4Completed
Phase 4, randomised, double-blind trial in neuropathic pain comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Change in median pain intensity of spontaneous pain at 5 weeks. Started Nov 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00252954.